SISCAPA Assay Technologies, Inc. — Form D
SISCAPA Assay Technologies, Inc. of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-11. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-04-11
- Form: D
- Accession: 0001528248-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 8
- Date of first sale: 2014-04-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-215393
Issuer
- Name: SISCAPA Assay Technologies, Inc.
- CIK: 0001528248
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 1759 WILLARD ST NW, WASHINGTON, DC, 20009
- Phone: (301) 728-1451
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| N. Leigh Anderson | Director | Washington, DC |
| Guo-Liang W Yu | Director | Washington, DC |
| N. Leigh Anderson | Executive Officer | Washington, DC |
| N. Leigh Anderson | Promoter | Washington, DC |
| Constance L Seniff | Promoter | Washington, DC |
| Constance L Seniff | Director | Washington, DC |
| Constance L Seniff | Executive Officer | Washington, DC |
| Terry W Pearson | Director | Washington, DC |
| Norman Liegh Anderson | Director | Washington, DC |
| Norman Liegh Anderson | Executive Officer | Washington, DC |
| Gus W Salem | Director | Washington, DC |
| Terry W. Pearson | Director | Washington, DC |
| Constance L. Seniff | Director | Washington, DC |
| Constance L. Seniff | Executive Officer | Washington, DC |
| Constance L. Seniff | Promoter | Washington, DC |
| Guo-Liang W. Yu | Director | Washington, DC |
Other filings by this issuer (2)
More